Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial.
Ann Rheum Dis. 2011 Jun;70(6):1003-9. doi: 10.1136/ard.2010.143974. Epub 2011 Mar 11.
Ann Rheum Dis. 2011.
PMID: 21398330
Free PMC article.
Clinical Trial.
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial.
Gordon J, Udeh U, Doobay K, Magro C, Wildman H, Davids M, Mersten JN, Huang WT, Lyman S, Crow MK, Spiera RF.
Gordon J, et al. Among authors: mersten jn.
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-189-93. Epub 2014 Aug 15.
Clin Exp Rheumatol. 2014.
PMID: 25152211
Clinical Trial.
Item in Clipboard
Cite
Cite